Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TRTP-104
- Development stage
- Preclinical
- Lead developer
- CellinCells
- Modality
- Tissue Cells → Other Cell Types → Cell Therapies
01
Overview
TRTP-104 is an organoid-based regenerative therapy being developed by CellinCells for the treatment of hair loss (alopecia) and hyperpigmentation. The therapy utilizes organoid technology to regenerate relevant skin and hair follicle tissues, aiming to restore natural function and appearance. As a cell-based regenerative medicine, it represents a novel approach to dermatological conditions by focusing on tissue regeneration rather than just symptomatic treatment. The specific molecular targets are not disclosed, but the mechanism involves the use of three-dimensional tissue-like structures (organoids) to replace or repair damaged skin and hair structures.
Beyond the preview
Go deeper on TRTP-104.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TRTP-104.